Linked from

The 18 pages that link to Thalidomide, each with the reason it gives.

• StereochemistryBroader topic: Its case illustrates both stereochemical complexity and the limits of treating enantiomers as isolated forms.

• EnantiomerBroader topic: Its history illustrates why enantiomer-specific effects and in-body interconversion require careful study.

• StereoisomerismBroader topic: Its stereochemistry illustrates why molecular configuration matters in pharmacology.

• Racemic mixtureBroader topic: Its enantiomeric behavior illustrates why a racemate cannot be assessed by optical rotation alone.

• StereoisomerBroader topic: Its stereochemical behavior became a cautionary case in drug development, though racemization complicates the enantiomer story.

• TeratologyBroader topic: Its effects exposed the danger of evaluating medicines without adequate developmental testing.

• Drug repurposingBroader topic: Its later use in multiple myeloma exemplifies repurposing after its biological effects were reconsidered.

• TeratogenicityBroader topic: Its effects revealed the danger of inadequate pregnancy safety evidence.

• Optical isomerismBroader topic: Its history shows why assigning different effects to isolated enantiomers requires careful evidence.

• R–S notationBroader topic: Its stereochemistry illustrates why configurations and interconversion must be treated carefully in drug discussions.

• Absolute configurationBroader topic: Its stereochemistry illustrates why an R/S label alone does not ensure a stable, isolated enantiomer.

• RacemizationBroader topic: Its interconversion illustrates why administering one enantiomer does not always prevent exposure to the other.

• StereocenterBroader topic: Its history illustrates why stereochemical structure and biological effects require careful interpretation.